Conduit Pharmaceuticals Inc. (CDT)
NASDAQ: CDT · Real-Time Price · USD
0.117
+0.025 (26.97%)
Nov 21, 2024, 12:47 PM EST - Market open
Conduit Pharmaceuticals Employees
Conduit Pharmaceuticals had 7 employees as of December 31, 2023.
Employees
7
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,164,429
Market Cap
11.96M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| IM Cannabis | 95 |
| RedHill Biopharma | 53 |
| Jaguar Health | 49 |
| Vaccinex | 40 |
| Soligenix | 15 |
| Cardio Diagnostics Holdings | 9 |
CDT News
- 5 hours ago - Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders - GlobeNewsWire
- 1 day ago - Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors - GlobeNewsWire
- 17 days ago - Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline - GlobeNewsWire
- 19 days ago - Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes - GlobeNewsWire
- 3 months ago - Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders - GlobeNewsWire
- 3 months ago - Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments - GlobeNewsWire
- 6 months ago - AstraZeneca furthers ambition to transform outcomes in early lung cancer and redefine metastatic breast cancer treatment at ASCO 2024 - Business Wire
- 6 months ago - Daiichi Sankyo Highlights Progress in Creating New Standards of Care for Patients Across Multiple Cancers at ASCO - Business Wire